Erratum: MicroRNA‑92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7 (Oncology Reports (2015) 34 (2576-2584) DOI: 10.3892/or.2015.4210);MicroRNA-92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7

Oncology Reports

Volumn 34, Issue 5, 2015, Pages 2576-2584

  Yang, Wei ^a   Dou, Changwei ^a   Wang, Yufeng ^a   Jia, Yuli ^a   Li, Chao ^a   Zheng, Xin ^a   Tu, Kangsheng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle; FBXW7; Hepatocellular carcinoma; MicroRNA 92a; Proliferation

Indexed keywords

MICRORNA; MICRORNA 92A; PEPTIDES AND PROTEINS; PROTEIN FBXW7; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; F BOX PROTEIN; FBXW7 PROTEIN, HUMAN; MIRN92 MICRORNA, HUMAN; UBIQUITIN PROTEIN LIGASE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RECURRENCE FREE SURVIVAL; ANIMAL; CANCER TRANSPLANTATION; CELL CYCLE; GENETICS; HEPG2 CELL LINE; LIVER TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR CELL LINE; UPREGULATION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; F-BOX PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, NUDE; MICRORNAS; NEOPLASM TRANSPLANTATION; PROGNOSIS; SURVIVAL ANALYSIS; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION;

EID: 84941951872     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2023.8596     Document Type: Erratum

References (31)

1. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
2. Kloosterman WP and Plasterk RH: The diverse functions of microRNAs in animal development and disease. Dev Cell 11: 441-450, 2006.
3. Szabo G and Bala S: MicroRNAs in liver disease. Nat Rev Gastroenterol Hepatol 10: 542-552, 2013.
4. Mendell JT: MicroRNAs: Critical regulators of development, cellular physiology and malignancy. Cell Cycle 4: 1179-1184, 2005.
5. Tu K, Zheng X, Dou C, Li C, Yang W, Yao Y and Liu Q: MicroRNA-130b promotes cell aggressiveness by inhibiting peroxisome proliferator-activated receptor gamma in human hepatocellular carcinoma. Int J Mol Sci 15: 20486-20499, 2014.
6. Ranade AR, Cherba D, Sridhar S, Richardson P, Webb C, Paripati A, Bowles B and Weiss GJ: MicroRNA 92a-2: A biomarker predictive for chemoresistance and prognostic for survival in patients with small cell lung cancer. J Thorac Oncol 5: 1273-1278, 2010.
7. Chen ZL, Zhao XH, Wang JW, Li BZ, Wang Z, Sun J, Tan FW, Ding DP, Xu XH, Zhou F, et al: microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin. J Biol Chem 286: 10725-10734, 2011.
8. Wu CW, Ng SS, Dong YJ, Ng SC, Leung WW, Lee CW, Wong YN, Chan FK, Yu J and Sung JJ: Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. Gut 61: 739-745, 2012.
9. Nilsson S, Möller C, Jirström K, Lee A, Busch S, Lamb R and Landberg G: Downregulation of miR-92a is associated with aggressive breast cancer features and increased tumour macrophage infiltration. PLoS One 7: e36051, 2012.
10. Ohyagi-Hara C, Sawada K, Kamiura S, Tomita Y, Isobe A, Hashimoto K, Kinose Y, Mabuchi S, Hisamatsu T, Takahashi T, et al: miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin α5 expression. Am J Pathol 182: 1876-1889, 2013.
11. Zhou C, Shen L, Mao L, Wang B, Li Y and Yu H: miR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7. Biochem Biophys Res Commun 458: 63-69, 2015.
12. Ranji N, Sadeghizadeh M, Shokrgozar MA, Bakhshandeh B, Karimipour M, Amanzadeh A and Azadmanesh K: MiR-17-92 cluster: An apoptosis inducer or proliferation enhancer. Mol Cell Biochem 380: 229-238, 2013.
13. Lin HY, Chiang CH and Hung WC: STAT3 upregulates miR-92a to inhibit RECK expression and to promote invasiveness of lung cancer cells. Br J Cancer 109: 731-738, 2013.
14. Ke TW, Wei PL, Yeh KT, Chen WT and Cheng YW: MiR-92a Promotes Cell Metastasis of Colorectal Cancer Through PTEN-Mediated PI3K/AKT Pathway. Ann Surg Oncol 22; 2649-2655, 2014.
15. Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY, Zhang JF, Shen HB, Zhang CY and Zen K: Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res 70: 9798-9807, 2010.
16. Shigoka M, Tsuchida A, Matsudo T, Nagakawa Y, Saito H, Suzuki Y, Aoki T, Murakami Y, Toyoda H, Kumada T, et al: Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development. Pathol Int 60: 351-357, 2010.
17. Tu K, Zheng X, Zhou Z, Li C, Zhang J, Gao J, Yao Y and Liu Q: Recombinant human adenovirus-p53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 pathway, which controls c-Myc and cyclin E. PLoS One 8: e68574, 2013.
18. Tu K, Yang W, Li C, Zheng X, Lu Z, Guo C, Yao Y and Liu Q: Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma. Mol Cancer 13: 110, 2014.
19. Tu K, Zheng X, Zan X, Han S, Yao Y and Liu Q: Evaluation of Fbxw7 expression and its correlation with the expression of c-Myc, cyclin E and p53 in human hepatocellular carcinoma. Hepatol Res 42: 904-910, 2012.
20. Liu Z, Tu K and Liu Q: Effects of microRNA-30a on migration, invasion and prognosis of hepatocellular carcinoma. FEBS Lett 588: 3089-3097, 2014.
21. Lv XB, Zhang X, Deng L, Jiang L, Meng W, Lu Z and Wang X: MiR-92a mediates AZD6244 induced apoptosis and G1-phase arrest of lymphoma cells by targeting Bim. Cell Biol Int 38: 435-443, 2014.
22. Li M, Guan X, Sun Y, Mi J, Shu X, Liu F and Li C: miR-92a family and their target genes in tumorigenesis and metastasis. Exp Cell Res 323: 1-6, 2014.
23. Welcker M, Orian A, Jin J, Grim JE, Harper JW, Eisenman RN and Clurman BE: The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad Sci USA 101: 9085-9090, 2004.
24. Koepp DM, Schaefer LK, Ye X, Keyomarsi K, Chu C, Harper JW and Elledge SJ: Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science 294: 173-177, 2001.
25. Grandori C, Cowley SM, James LP and Eisenman RN: The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 16: 653-699, 2000.
26. Hwang HC and Clurman BE: Cyclin E in normal and neoplastic cell cycles. Oncogene 24: 2776-2786, 2005.
27. Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM and Pagano M: Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol 15: 2612-2624, 1995.
28. Prendergast GC: Mechanisms of apoptosis by c-Myc. Oncogene 18: 2967-2987, 1999.
29. Sargent LM, Zhou X, Keck CL, Sanderson ND, Zimonjic DB, Popescu NC and Thorgeirsson SS: Nonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-Myc and transforming growth factor-alpha in the liver. Am J Pathol 154: 1047-1055, 1999.
30. Li K, Lin SY, Brunicardi FC and Seu P: Use of RNA interference to target cyclin E-overexpressing hepatocellular carcinoma. Cancer Res 63: 3593-3597, 2003.
31. Xu MZ, Chan SW, Liu AM, Wong KF, Fan ST, Chen J, Poon RT, Zender L, Lowe SW, Hong W, et al: AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma. Oncogene 30: 1229-1240, 2011.